|
May 11, 2023
|
Nkarta Reports First Quarter 2023 Financial Results and Corporate Highlights
|
|
|
May 11, 2023
|
Nkarta to Present NKX019 Phase 1 Dose Escalation Data at European Hematology Association 2023 Congress and 17th International Conference on Malignant Lymphoma
|
|
|
Apr 17, 2023
|
Nkarta Presents Preclinical Data Exploring Gene Knockout Strategies and Combination Agents with NK Cell-Based Therapies at the 2023 AACR Annual Meeting
|
|
|
Apr 12, 2023
|
Nkarta to Participate at Upcoming Investor Conferences
|
|
|
Mar 30, 2023
|
Nkarta Announces Departure of Chief Financial & Business Officer
|
|
|
Mar 16, 2023
|
Nkarta Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights
|
|
|
Feb 09, 2023
|
Nkarta to Participate at Upcoming Investor Conferences
|
|
|
Jan 09, 2023
|
Nkarta Promotes David R. Shook, M.D., to Chief Medical Officer
|
|
